Deerland’s probiotic attains food-health relationship claims in Australia and New Zealand
07 Apr 2021 --- Deerland Probiotics & Enzymes’ probiotic Bacillus subtilis DE11 has attained a list of published health claims in relation to its inclusion as a food ingredient under the Food Standards Australia New Zealand (FSANZ) Code.
The move makes DE111 the first Bacillus subtilis probiotic to have food-health supported claims associated with its use in this geographic market of food products.
“This opens up many opportunities for brands to meet the growing demand for probiotic products by enhancing their food and beverages with functionality, communicated through science-backed claims,” says Steen Andersen, president of the company.
The claims include “promotes the growth of healthy gastrointestinal flora,” “supports the growth of beneficial gut bacteria,” “supports and improves digestive health in children and adults,” and “reduces total blood cholesterol or blood LDL cholesterol.”
Food-health relationship
Currently, companies seeking to make a general level health claim for a food ingredient in Australia and New Zealand must perform a comprehensive and systematic review of the evidence of a causal food-health relationship.
The move allows brands to meet the growing demand for probiotic products by enhancing them with functionality claims.The global supplier of microbiome health solutions was able to conduct this assessment of the probiotic based on the wealth of peer-reviewed clinical publications on the strain.
“DE111 provides unique, specific claims and connects consumers’ growing interest in self-care with products that can deliver on their needs,” explains Simon Lord, Deerland’s director of sales for Australia and New Zealand.
In addition to the published notification of claims, DE111 has received a letter of no-objection on its generally recognized as safe (GRAS) status from the US Food and Drug Administration (FDA), non-Novel Food status in both Canada and Australia, as well as approval as a natural health ingredient by Health Canada.
Furthermore, DE111 is Star-K Kosher certified and Non-GMO Project verified.
Recently, Deerland also shared the results of a new clinical study examining the immune support effects of Bacillus subtilis DE111.
Researchers examined peripheral blood mononuclear cells at basal levels pre-and post-study.
They also studied the response to stimulation with bacterial lipopolysaccharide, which encourages neutrophils, macrophages and other innate immune cells to release proinflammatory cytokines.
Moreover, the company changed its brand tagline to “Motivated by science, measured by wellness.” Deerland says the line fits with its brand identity for a vision “for all people of all cultures to benefit from its enzyme, probiotic and prebiotic health products,” along with its mission “to measurably improve the quality of people’s lives by creating innovative, scientifically sound products, services and technology.”
Edited by Kristiana Lalou
